首页> 外文期刊>Experimental and clinical transplantation >Ex Vivo Lung Perfusion and Transplant: State of the Art and View to the Future
【24h】

Ex Vivo Lung Perfusion and Transplant: State of the Art and View to the Future

机译:体外肺灌注和移植:最新技术和对未来的展望

获取原文
           

摘要

After the first clinical application of ex vivo lung perfusion in 2001, the technique has been used in many lung transplant centers worldwide. In addition, many modifications have been tested, leading to the development of various ex vivo lung perfusion systems and application protocols. Currently, the Lund protocol, the Toronto protocol, and Organ Care System Lung protocol are the clinically applied ex vivo lung perfusion protocols, based on the favorable results of the safety studies. Accordingly, the comparison among these EVLP systems and protocols should be an important research target, in order to provide the evidence based medical data that would recommend one protocol over the others. In this manuscript, the current experience with EVLP is reviewed and some molecular and clinical targets, that could be used to compare the various protocols of the technique, are introduced.
机译:自2001年首次临床应用离体肺灌注后,该技术已在全球许多肺移植中心使用。另外,已经测试了许多修饰,从而导致了各种离体肺灌注系统和应用方案的发展。当前,基于安全性研究的良好结果,Lund方案,Toronto方案和Organ Care System Lung方案是临床应用的离体肺灌注方案。因此,这些EVLP系统和协议之间的比较应该成为重要的研究目标,以便提供基于证据的医学数据,从而推荐一种协议。在本手稿中,对EVLP的当前经验进行了回顾,并介绍了一些可用于比较该技术各种方案的分子和临床靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号